CHARVIN, DELPHINE,MANTEAU, BAPTISTE,POMEL, VINCENT,CONQUET, FRANÇOIS
申请号:
PL15770814
公开号:
PL3186257T3
申请日:
2015.08.27
申请国别(地区):
PL
年份:
2019
代理人:
摘要:
The present invention provides a novel chromone oxime derivative of formula (I), which is a modulator of nervous system receptors sensitive to glutamate and, furthermore, presents an advantageously high brain penetration upon oral administration. The invention also relates to a pharmaceutical composition containing this compound, and to its use for the treatment or prevention of conditions associated with altered glutamatergic signalling and/or functions, or conditions which can be affected by alteration of glutamate level or signalling, particularly acute and chronic neurological and/or psychiatric disorders.